Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Pliant Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 161
- +11 vs. Q3 2024
- Shares held
- 64.8M
- +1.55M (+2.5%) vs. Q3 2024
- Total value
- $852.6M
- +$145.2M (+20.5%) vs. Q3 2024
- New holders
- 24
- 55 more added
- Sold out
- 13
- 43 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $54.8M |
| Q1 2026 | 91 | $62.5M |
| Q4 2025 | 98 | $57.0M |
| Q3 2025 | 100 | $74.7M |
| Q2 2025 | 114 | $59.7M |
| Q1 2025 | 141 | $78.5M |
| Q4 2024 | 161 | $852.6M |
| Q3 2024 | 151 | $710.6M |
| Q2 2024 | 144 | $687.2M |
| Q1 2024 | 135 | $971.3M |
| Q4 2023 | 134 | $1.14B |
| Q3 2023 | 136 | $1.04B |
| Q2 2023 | 144 | $1.05B |
| Q1 2023 | 143 | $1.50B |
| Q4 2022 | 125 | $864.1M |
| Q3 2022 | 110 | $948.1M |
| Q2 2022 | 88 | $241.5M |
| Q1 2022 | 92 | $222.1M |
| Q4 2021 | 88 | $416.5M |
| Q3 2021 | 77 | $512.8M |
| Q2 2021 | 81 | $893.6M |
| Q1 2021 | 76 | $1.21B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Pliant Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harbor Capital Advisors, Inc. | 95,801 | $1.26M | 0.06% | +3,822+4.2% | Added |
| Two Sigma Investments, LP | 97,078 | $1.28M | 0.00% | −38,044−28.2% | Reduced |
| American Century Companies Inc | 100,849 | $1.33M | 0.00% | +9,944+10.9% | Added |
| Barclays PLC | 101,823 | $1.34M | 0.00% | −319,676−75.8% | Reduced |
| Exome Asset Management LLC | 103,504 | $1.36M | 1.03% | −46,096−30.8% | Reduced |
| UBS Oconnor LLC | 103,563 | $1.36M | 0.03% | +18,678+22.0% | Added |
| Algert Global LLC | 107,603 | $1.42M | 0.03% | +1,041+1.0% | Added |
| Hennion & Walsh Asset Management, Inc. | 108,608 | $1.43M | 0.06% | +16,634+18.1% | Added |
| Royal Bank of Canada | 112,517 | $1.48M | 0.00% | +6,947+6.6% | Added |
| Rhenman & Partners Asset Management AB | 116,250 | $1.53M | 0.16% | −4,000−3.3% | Reduced |
| Bank of America Corp | 120,977 | $1.59M | 0.00% | −506,719−80.7% | Reduced |
| Woodline Partners LP | 127,295 | $1.68M | 0.01% | +15,635+14.0% | Added |
| Atom Investors LP | 130,448 | $1.72M | 0.21% | +130,448 | New |
| ADAR1 Capital Management, LLC | 134,798 | $1.78M | 0.37% | −111,330−45.2% | Reduced |
| Two Sigma Advisers, LP | 135,700 | $1.79M | 0.00% | −22,100−14.0% | Reduced |
| UBS Asset Management Americas Inc | 139,574 | $1.84M | 0.00% | +21,637+18.3% | Added |
| Caption Management, LLC | 142,404 | $1.88M | 0.08% | +142,404 | New |
| Rice Hall James & Associates, LLC | 160,522 | $2.11M | 0.12% | +3,305+2.1% | Added |
| Jane Street Group, LLC | 182,015 | $2.40M | 0.00% | −4,711−2.5% | Reduced |
| Bank of New York Mellon Corp | 184,382 | $2.43M | 0.00% | −172−0.1% | Reduced |
| JPMorgan Chase & Co | 197,251 | $2.60M | 0.00% | +148,039+300.8% | Added |
| Nuveen Asset Management, LLC | 206,947 | $2.73M | 0.00% | −128,533−38.3% | Reduced |
| ArrowMark Colorado Holdings LLC | 281,189 | $3.70M | 0.05% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 297,362 | $3.92M | 0.72% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 300,000 | $3.95M | 0.35% | 00.0% | Unchanged |
| AXA S.A. | 346,941 | $4.57M | 0.01% | −546−0.2% | Reduced |
| Citadel Advisors LLC | 401,689 | $5.29M | 0.00% | +366,635+1,045.9% | Added |
| Rock Springs Capital Management LP | 404,796 | $5.33M | 0.20% | +19,800+5.1% | Added |
| Fernwood Investment Management, LLC | 425,424 | $5.60M | 1.95% | −87,712−17.1% | Reduced |
| Goldman Sachs Group Inc | 446,700 | $5.88M | 0.00% | +99,303+28.6% | Added |
| Charles Schwab Investment Management Inc | 459,384 | $6.05M | 0.00% | +2,721+0.6% | Added |
| Granahan Investment Management Inc | 527,147 | $6.94M | 0.29% | −211,105−28.6% | Reduced |
| Bessemer Group Inc | 532,174 | $7.01M | 0.01% | 00.0% | Unchanged |
| Checkpoint Capital L.P. | 535,494 | $7.05M | 3.59% | +155,494+40.9% | Added |
| Dimensional Fund Advisors LP | 547,297 | $7.21M | 0.00% | +91,131+20.0% | Added |
| Northern Trust Corp | 555,600 | $7.32M | 0.00% | +53,584+10.7% | Added |
| UBS Group AG | 628,281 | $8.27M | 0.00% | +397,973+172.8% | Added |
| Adage Capital Partners GP, L.L.C. | 649,660 | $8.56M | 0.01% | +649,660 | New |
| Logos Global Management LP | 750,000 | $9.88M | 1.16% | +750,000 | New |
| Morgan Stanley | 782,004 | $10.3M | 0.00% | −35,119−4.3% | Reduced |
| Candriam Luxembourg S.C.A. | 900,104 | $11.9M | 0.07% | +66,888+8.0% | Added |
| Franklin Resources Inc | 1,045,577 | $13.8M | 0.00% | +5,673+0.5% | Added |
| Great Point Partners LLC | 1,055,000 | $13.9M | 6.55% | −855,121−44.8% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,120,803 | $14.8M | 0.61% | +1,120,803 | New |
| Pictet Asset Management Holding SA | 1,266,030 | $16.7M | 0.02% | −13,687−1.1% | Reduced |
| Ra Capital Management, L.P. | 1,281,000 | $16.9M | 0.22% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 1,315,601 | $17.3M | 3.87% | +1,315,601 | New |
| Geode Capital Management, LLC | 1,316,648 | $17.3M | 0.00% | −1,660−0.1% | Reduced |
| State Street Corp | 1,385,236 | $18.2M | 0.00% | −17,494−1.2% | Reduced |
| First Light Asset Management, LLC | 1,681,110 | $22.1M | 2.12% | −894,436−34.7% | Reduced |
| Polar Capital Holdings Plc | 2,015,000 | $26.5M | 0.15% | 00.0% | Unchanged |
| TRV GP IV, LLC | 2,132,867 | $28.1M | 35.03% | 00.0% | Unchanged |
| Deutsche Bank AG | 2,551,865 | $33.6M | 0.01% | +1,017,500+66.3% | Added |
| Blue Owl Capital Holdings LP | 2,769,199 | $36.5M | 8.62% | −235,000−7.8% | Reduced |
| Redmile Group, LLC | 2,895,478 | $38.1M | 2.66% | −302,013−9.4% | Reduced |
| Paradigm Biocapital Advisors LP | 3,197,050 | $42.1M | 1.46% | +92,564+3.0% | Added |
| Vanguard Group Inc | 3,228,755 | $42.5M | 0.00% | −297,759−8.4% | Reduced |
| FMR LLC | 3,876,598 | $51.1M | 0.00% | −22,883−0.6% | Reduced |
| Price T Rowe Associates Inc | 4,634,486 | $61.0M | 0.01% | −200,327−4.1% | Reduced |
| BlackRock, Inc. | 5,179,977 | $68.2M | 0.00% | −38,988−0.7% | Reduced |
| Deep Track Capital, LP | 5,972,257 | $78.7M | 2.95% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −244,640−100.0% | Sold out |
| Capital International Investors | 0 | $0 | 0.00% | −224,997−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| HarbourVest Partners LLC | 0 | $0 | 0.00% | −49,434−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −34,611−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −30,471−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −22,628−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −13,986−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,229−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −10,260−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −10,077−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Mass General Brigham, Inc | – | – | – | – | Not filed |